Tech Company Financing Transactions

OphthoTech Funding Round

OphthoTech, based in New York, scored $175 million in investment from Novo Ventures and private investors.

Transaction Overview

Company Name
Announced On
5/29/2013
Transaction Type
Venture Equity
Amount
$175,000,000
Round
Undisclosed
Investors

Novo Ventures (Lead Investor)

Proceeds Purpose
The financing of $175 million consists of $125 million from Novo A/S, in exchange for royalties on Fovista sales. The remaining $50 million is in the form of a Series C preferred stock financing from Novo A/S and current venture investors in Ophthotech. The royalty and Series C funding is structured in three equal tranches, the first of which has closed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Penn Plz. 3520
New York, NY 10119
USA
Email Address
Overview
Ophthotech Corporation (NASDAQ: OPHT) is a biopharmaceutical company focusing on discovering, developing and commercializing first-in-class therapies for the treatment of major ophthalmic diseases.
Profile
OphthoTech LinkedIn Company Profile
Social Media
OphthoTech Company Twitter Account
Company News
OphthoTech News
Facebook
OphthoTech on Facebook
YouTube
OphthoTech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Glenn Sblendorio
  Glenn Sblendorio LinkedIn Profile  Glenn Sblendorio Twitter Account  Glenn Sblendorio News  Glenn Sblendorio on Facebook
Chief Financial Officer
David Carroll
  David Carroll LinkedIn Profile  David Carroll Twitter Account  David Carroll News  David Carroll on Facebook
Chief Medical Officer
Kourous Rezaei
  Kourous Rezaei LinkedIn Profile  Kourous Rezaei Twitter Account  Kourous Rezaei News  Kourous Rezaei on Facebook
Chief Operating Officer
Evelyn Harrison
  Evelyn Harrison LinkedIn Profile  Evelyn Harrison Twitter Account  Evelyn Harrison News  Evelyn Harrison on Facebook
Chief Operating Officer
Keith Westby
  Keith Westby LinkedIn Profile  Keith Westby Twitter Account  Keith Westby News  Keith Westby on Facebook
VP - General Counsel
Todd Anderman
  Todd Anderman LinkedIn Profile  Todd Anderman Twitter Account  Todd Anderman News  Todd Anderman on Facebook
VP - Human Resources
Amy Sheehan
  Amy Sheehan LinkedIn Profile  Amy Sheehan Twitter Account  Amy Sheehan News  Amy Sheehan on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/28/2013: Appurify venture capital transaction
Next: 5/29/2013: DoYouRemember venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary